×

Light therapy treatment

  • US 9,610,460 B2
  • Filed: 08/29/2014
  • Issued: 04/04/2017
  • Est. Priority Date: 05/01/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method comprising:

  • identifying an ischemic event in a patient;

    selecting one or more wavelength ranges, from a plurality of wavelength ranges, based on the ability of the wavelength range to inhibit cytochrome c oxidase;

    generating light at the one or more selected wavelength ranges, wherein one of the selected wavelength ranges at which the light is generated includes 950 nm; and

    applying the light, prior to an onset of reperfusion, to organic tissue that has experienced the ischemic event.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×